Literature DB >> 23439671

Preeclampsia, gestational hypertension and subsequent hypothyroidism.

Tuija Männistö1, S Ananth Karumanchi, Anneli Pouta, Marja Vääräsmäki, Pauline Mendola, Satu Miettola, Heljä-Marja Surcel, Aini Bloigu, Aimo Ruokonen, Marjo-Riitta Järvelin, Anna-Liisa Hartikainen, Eila Suvanto.   

Abstract

OBJECTIVES: To evaluate the effect of preeclampsia (PE) and gestational hypertension (GH) on subsequent hypothyroidism. Recent studies suggest that women with PE have increased risk for reduced thyroid function, but the association between PE and GH with overt hypothyroidism has not been examined. STUDY
DESIGN: Two prospective population-based cohort studies, the Northern Finland Birth Cohorts 1966 and 1986, followed women who had PE (N=955), GH (N=1449) or were normotensive (N=13531) during pregnancy. Finnish national registers were used to confirm subsequent hypothyroidism. Adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs) estimated hypothyroidism risk when comparing women with PE or GH with normotensive women. MAIN OUTCOME MEASURES: Primary hypothyroidism during follow-up of 20-40 years.
RESULTS: The subsequent prevalence of hypothyroidism was higher among women with PE (4.0%) and GH (4.5%) compared with normotensive women (3.5%), but the risk increase was not significant (aHR for PE 1.13, 95%CI 0.80-1.59 and aHR for GH 1.11, 95%CI 0.85-1.45). Subgroup analysis among nulliparous women revealed a significant association between late PE and subsequent hypothyroidism (aHR 1.82, 95%CI 1.04-3.19). Early or recurrent PE were not associated with hypothyroidism (aHR 0.93, 95%CI 0.46-1.81 and aHR 1.35, 95%CI 0.63-2.88, respectively).
CONCLUSIONS: Overall, PE or GH during pregnancy was not significantly associated with subsequent hypothyroidism in Finnish women after 20-40 years of follow-up. However, late PE in nulliparous women was associated with a 1.8-fold increased risk of subsequent hypothyroidism, a finding that merits further study in other populations.

Entities:  

Keywords:  gestational hypertension; hypothyroidism; preeclampsia; thyroid

Year:  2012        PMID: 23439671      PMCID: PMC3578699          DOI: 10.1016/j.preghy.2012.09.001

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  31 in total

1.  A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib.

Authors:  Tejas V Patel; Jeffrey A Morgan; George D Demetri; Suzanne George; Robert G Maki; Michael Quigley; Benjamin D Humphreys
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

Review 2.  Long-term complications of preeclampsia.

Authors:  David Williams
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

3.  Disturbed feto-maternal cell traffic in preeclampsia.

Authors:  W Holzgreve; F Ghezzi; E Di Naro; D Gänshirt; E Maymon; S Hahn
Journal:  Obstet Gynecol       Date:  1998-05       Impact factor: 7.661

Review 4.  Groups at risk in low birth weight infants and perinatal mortality.

Authors:  P Rantakallio
Journal:  Acta Paediatr Scand       Date:  1969

5.  Ecological and individual predictors of birthweight in a northern Finland birth cohort 1986.

Authors:  M R Järvelin; P Elliott; I Kleinschmidt; M Martuzzi; C Grundy; A L Hartikainen; P Rantakallio
Journal:  Paediatr Perinat Epidemiol       Date:  1997-07       Impact factor: 3.980

Review 6.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy.

Authors:  Jennifer A Hutcheon; Sarka Lisonkova; K S Joseph
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-02-18       Impact factor: 5.237

7.  History of preeclampsia is not associated with an increased risk of thyroid dysfunction.

Authors:  Ruth R Dekker; Bram M Jochemsen; Maria G van Pampus; Job G Santema; Caroline Roozendaal; Henk Groen; Thera P Links; Jasper J van Doormaal
Journal:  Acta Obstet Gynecol Scand       Date:  2010-08       Impact factor: 3.636

8.  Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

Authors:  H Masuyama; T Segawa; Y Sumida; A Masumoto; S Inoue; Y Akahori; Y Hiramatsu
Journal:  BJOG       Date:  2009-12-10       Impact factor: 6.531

9.  Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

Authors:  Sarosh Rana; S Ananth Karumanchi; Richard J Levine; Shivalingappa Venkatesha; Jose Alejandro Rauh-Hain; Hector Tamez; Ravi Thadhani
Journal:  Hypertension       Date:  2007-05-21       Impact factor: 10.190

10.  The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation.

Authors:  P Wolter; C Stefan; B Decallonne; H Dumez; M Bex; P Carmeliet; P Schöffski
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

View more
  7 in total

Review 1.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

2.  The NOX2-derived reactive oxygen species damaged endothelial nitric oxide system via suppressed BKCa/SKCa in preeclampsia.

Authors:  Jie Chen; Qinqin Gao; Lin Jiang; Xueqin Feng; Xiaolin Zhu; Xiaorong Fan; Caiping Mao; Zhice Xu
Journal:  Hypertens Res       Date:  2017-01-12       Impact factor: 3.872

Review 3.  Pre-eclampsia and cardiovascular disease.

Authors:  Christina W Chen; Iris Z Jaffe; S Ananth Karumanchi
Journal:  Cardiovasc Res       Date:  2014-02-13       Impact factor: 10.787

4.  Effect of Preeclampsia on Ultrastructure of Thyroid Gland, Hepatic Type 1 Iodothyronine Deiodinase, and Thyroid Hormone Levels in Rats.

Authors:  Yunlu Liu; Zhuping Xu; Yanqin Li; Wenyan Jiang; Ming Lan; Xiaojuan Xie; Yang Wang
Journal:  Biomed Res Int       Date:  2021-04-20       Impact factor: 3.411

5.  Association of thyroid function test abnormalities with preeclampsia: a systematic review and meta-analysis.

Authors:  Mahboubeh Hajifoghaha; Saeed Hosseini Teshnizi; Sedighe Forouhari; Mohammad Hossein Dabbaghmanesh
Journal:  BMC Endocr Disord       Date:  2022-09-26       Impact factor: 3.263

Review 6.  Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when.

Authors:  T Katrien J Groenhof; Bas B van Rijn; Arie Franx; Jeanine E Roeters van Lennep; Michiel L Bots; A Titia Lely
Journal:  Eur J Prev Cardiol       Date:  2017-09-12       Impact factor: 7.804

7.  Hypothyroidism Alters the Uterine Lipid Levels in Pregnant Rabbits and Affects the Fetal Size.

Authors:  Julia Rodríguez-Castelán; Dafne Zepeda-Pérez; Maribel Méndez-Tepepa; Marlenne Castillo-Romano; Marlen Espíndola-Lozano; Arely Anaya-Hernández; Pere Berbel; Estela Cuevas-Romero
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2019       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.